Status:
COMPLETED
Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy
Lead Sponsor:
Henning Bundgaard
Conditions:
Hypertrophic Cardiomyopathy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Objective The objective of the study is to assess the structural and functional cardiac effects of treatment with losartan in patients with hypertrophic cardiomyopathy (HCM). Design The study is a ra...
Eligibility Criteria
Inclusion
- Hypertrophic cardiomyopathy
- \> 18 years
- Sinus rhythm
Exclusion
- EF \< 50 %
- Treatment with RAS-inhibitor
- Contraindications to losartan
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01447654
Start Date
November 1 2011
End Date
June 1 2014
Last Update
July 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of cardiology, Rigshospitalet.
Copenhagen, Denmark, 2100